Chemical genetic identification of peptidoglycan inhibitors potentiating carbapenem activity against methicillin-resistant Staphylococcus aureus.

Methicillin-resistant Staphylococcus aureus (MRSA) is a major nosocomial and community-acquired pathogen for which few existing antibiotics are efficacious. Here we describe two structurally related synthetic compounds that potentiate beta-lactam activity against MRSA. Genetic studies indicate that these agents target SAV1754 based on the following observations: (i) it has a unique chemical hypersensitivity profile, (ii) overexpression or point mutations are sufficient to confer resistance, and (iii) genetic inactivation phenocopies the potentiating effect of these agents in combination with beta-lactams. Further, we demonstrate these agents inhibit peptidoglycan synthesis. Because SAV1754 is essential for growth and structurally related to the recently reported peptidoglycan flippase of Escherichia coli, we speculate it performs an analogous function in S. aureus. These results suggest that SAV1754 inhibitors might possess therapeutic potential alone, or in combination with beta-lactams to restore MRSA efficacy.

[1]  J. Gossett,et al.  Isolation of a bacterium that reductively dechlorinates tetrachloroethene to ethene. , 1997, Science.

[2]  A. Tomasz,et al.  Normally functioning murF is essential for the optimal expression of methicillin resistance in Staphylococcus aureus. , 2003, Microbial drug resistance.

[3]  J. Iandolo,et al.  High-frequency transformation ofStaphylococcus aureus by electroporation , 1990, Current Microbiology.

[4]  A. Tomasz,et al.  Antibiotic resistance as a stress response: complete sequencing of a large number of chromosomal loci in Staphylococcus aureus strain COL that impact on the expression of resistance to methicillin. , 1999, Microbial drug resistance.

[5]  P. Bradford,et al.  Late stage antibacterial drugs in the clinical pipeline. , 2007, Current opinion in microbiology.

[6]  N. Ruiz.  Bioinformatics identification of MurJ (MviN) as the peptidoglycan lipid II flippase in Escherichia coli , 2008, Proceedings of the National Academy of Sciences.

[7]  K. Marotti,et al.  Resistance mapping and mode of action of a novel class of antibacterial anthranilic acids: evidence for disruption of cell wall biosynthesis. , 2008, The Journal of antimicrobial chemotherapy.

[8]  D. Hospenthal,et al.  Annals of Clinical Microbiology and Antimicrobials Open Access Presumptive Identification of Candida Species Other than C. Albicans, C. Krusei, and C. Tropicalis with the Chromogenic Medium Chromagar Candida , 2006 .

[9]  B. Berger-Bächi,et al.  Mapping and characterization of multiple chromosomal factors involved in methicillin resistance in Staphylococcus aureus , 1992, Antimicrobial Agents and Chemotherapy.

[10]  K. Bush,et al.  Anti-MRSA β-lactams in development, with a focus on ceftobiprole: the first anti-MRSA β-lactam to demonstrate clinical efficacy , 2007 .

[11]  B. Stockwell,et al.  Multicomponent therapeutics for networked systems , 2005, Nature Reviews Drug Discovery.

[12]  D. Pompliano,et al.  Drugs for bad bugs: confronting the challenges of antibacterial discovery , 2007, Nature Reviews Drug Discovery.

[13]  L. Silver.  Novel inhibitors of bacterial cell wall synthesis. , 2003, Current opinion in microbiology.

[14]  C. Walsh.  Molecular mechanisms that confer antibacterial drug resistance , 2000, Nature.

[15]  N. McCallum,et al.  The gate controlling cell wall synthesis in Staphylococcus aureus , 2004, Molecular microbiology.

[16]  H. Takahashi,et al.  Involvement of an Essential Gene, mviN, in Murein Synthesis in Escherichia coli , 2008, Journal of bacteriology.

[17]  A. Tomasz,et al.  An acquired and a native penicillin-binding protein cooperate in building the cell wall of drug-resistant staphylococci , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[18]  C. Walsh,et al.  Intracellular steps of bacterial cell wall peptidoglycan biosynthesis: enzymology, antibiotics, and antibiotic resistance. , 1992, Natural product reports.

[19]  N. Ruiz.  Streptococcus pyogenes YtgP (Spy_0390) Complements Escherichia coli Strains Depleted of the Putative Peptidoglycan Flippase MurJ , 2009, Antimicrobial Agents and Chemotherapy.

[20]  Howard Xu,et al.  A genome‐wide strategy for the identification of essential genes in Staphylococcus aureus , 2002, Molecular microbiology.

[21]  A. Patchett,et al.  Antibacterial Agents That Inhibit Lipid A Biosynthesis , 1996, Science.

[22]  F. Ishino,et al.  Molecular cloning of the gene of a penicillin-binding protein supposed to cause high resistance to beta-lactam antibiotics in Staphylococcus aureus , 1986, Journal of bacteriology.

[23]  Stanley N Cohen,et al.  SOS Response Induction by ß-Lactams and Bacterial Defense Against Antibiotic Lethality , 2004, Science.

[24]  B. Berger-Bächi,et al.  The essential Staphylococcus aureus gene fmhB is involved in the first step of peptidoglycan pentaglycine interpeptide formation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[25]  A. Tomasz,et al.  Role of a Sodium-Dependent Symporter Homologue in the Thermosensitivity of β-Lactam Antibiotic Resistance and Cell Wall Composition in Staphylococcus aureus , 2007, Antimicrobial Agents and Chemotherapy.

[26]  L. Silver,et al.  Multi-targeting by monotherapeutic antibacterials , 2007, Nature Reviews Drug Discovery.

[27]  A. Tomasz,et al.  Methicillin Resistance in Staphylococcus Essential for Expression of High-level Reassessment of the Number of Auxiliary Genes , 2022 .

[28]  R. Levesque,et al.  Structure and function of the Mur enzymes: development of novel inhibitors , 2002, Molecular microbiology.

[29]  M. G. Pinho,et al.  Bacterial Cell Wall Synthesis: New Insights from Localization Studies , 2005, Microbiology and Molecular Biology Reviews.

[30]  Sang Ho Lee,et al.  A Staphylococcus aureus fitness test platform for mechanism-based profiling of antibacterial compounds. , 2009, Chemistry & biology.

[31]  Roberta B Carey,et al.  Invasive methicillin-resistant Staphylococcus aureus infections in the United States. , 2007, JAMA.

[32]  J. Blanchard,et al.  Meropenem-Clavulanate Is Effective Against Extensively Drug-Resistant Mycobacterium tuberculosis , 2009, Science.

[33]  D. Sahm,et al.  Laboratory-based surveillance of current antimicrobial resistance patterns and trends among Staphylococcus aureus: 2005 status in the United States , 2006, Annals of Clinical Microbiology and Antimicrobials.

[34]  R. Kishony,et al.  Functional classification of drugs by properties of their pairwise interactions , 2006, Nature Genetics.

[35]  A. Tomasz,et al.  Complementation of the Essential Peptidoglycan Transpeptidase Function of Penicillin-Binding Protein 2 (PBP2) by the Drug Resistance Protein PBP2A in Staphylococcus aureus , 2001, Journal of bacteriology.

[36]  J. Heijenoort.  Recent advances in the formation of the bacterial peptidoglycan monomer unit (1985 to 2000) , 2001 .

[37]  M. G. Pinho,et al.  Staphylococcus aureus PBP4 Is Essential for β-Lactam Resistance in Community-Acquired Methicillin-Resistant Strains , 2008, Antimicrobial Agents and Chemotherapy.

[38]  Rapid method for the identification of essential genes in Staphylococcus aureus. , 1999, Plasmid.

[39]  A. Tomasz,et al.  Role of murE in the Expression of β-Lactam Antibiotic Resistance in Staphylococcus aureus , 2004, Journal of bacteriology.

[40]  A. Tomasz,et al.  Antibiotic resistant Staphylococcus aureus: a paradigm of adaptive power. , 2007, Current opinion in microbiology.

[41]  Elizabeth A Bancroft,et al.  Antimicrobial resistance: it's not just for hospitals. , 2007, JAMA.

[42]  B. Berger-Bächi,et al.  Factors influencing methicillin resistance in staphylococci , 2002, Archives of Microbiology.

[43]  J. Errington,et al.  Dispersed mode of Staphylococcus aureus cell wall synthesis in the absence of the division machinery , 2003, Molecular microbiology.

[44]  D. Green.  The bacterial cell wall as a source of antibacterial targets , 2002, Expert opinion on therapeutic targets.

[45]  F. Ishino,et al.  Evolution of an inducible penicillin‐target protein in methicillin‐resistant Staphylococcus aureus by gene fusion , 1987, FEBS letters.